![]()
|
|
||||||||
(Received for publication, October 2, 1996, and in revised form, January 3, 1997)
From the Laboratory of Molecular Pharmacology, Division of Basic
Sciences, NCI, National Institutes of Health, Bethesda, Maryland
20892
Abasic sites and deamination of cytosine to
uracil are probably the most common types of endogenous DNA damage. The
effects of such lesions on DNA topoisomerase I (top1) activity were
examined in oligonucleotides containing a unique top1 cleavage site.
The presence of uracils and abasic sites within the first 4 bases immediately 5 Abasic sites are the most common endogenous lesions found in
DNA, with an estimated 10,000 lesions per human cell per day (1). They
arise spontaneously by hydrolysis of the glycosidic bond primarily to
purine bases. They are also produced during the course of excision
repair of base damage due to oxidation or alkylation during normal
metabolism and during the repair of exogenous damage by ionizing
radiation, environmental carcinogens, or drugs used in cancer
chemotherapy. Ubiquitous uracil N-glycosylase also processes
uridines in DNA to abasic sites (for review, see Refs. 1-3). The
occurrence of uracil, generated from the spontaneous deamination of
cytosine, has been estimated at 100-500 per human cell per day
(1).
Mammalian DNA topoisomerases (including
top11) are ubiquitous enzymes involved in
multiple processes, including DNA replication, transcription, and
illegitimate recombination (4). top1 acts as a monomer, binds to duplex
DNA, and creates transient single-strand breaks via the formation of
covalent adducts between the 3 In this study, we examined the effect of uracil incorporation and
abasic site generation on top1 cleavage activity and demonstrate that
these frequent DNA lesions can, depending on their location relative to
the top1 cleavage site, inhibit the catalytic activity of the enzyme or
trap top1 on DNA. Recently, in vitro cleavage of another
mammalian topoisomerase, the type II enzyme, was found to be enhanced
by the introduction of abasic sites into DNA substrates (16).
Oligonucleotides were purchased from
Midland Certified Reagent Co. (Midland, TX).
The scissile
(upper) strand of the duplex oligonucleotides (see Figs. 1, 2, 3, 4, 5) were
labeled with
Double-stranded oligonucleotides containing uracils at
different positions were treated for 2 h at 30 °C with 1 unit
(1 µl) of uracil DNA glycosylase (Life Technologies, Inc.) to create an abasic site at the equivalent position (31). The buffer used was the
same as for annealing (10 mM Tris·HCl, pH 7.8, 100 mM NaCl, 1 mM EDTA). The reaction mixture was
then centrifuged through a G25 Sephadex column and used in the top1
reactions. The efficiency of abasic site formation by uracil DNA
glycosylase was verified by the nicking of over 80% of the
oligonucleotide at the abasic site in the presence of 10 mM
NaOH (1 h at 25 °C) (see Fig. 5B, lane d). The
tetrahydrofuran oligonucleotide used in Fig. 6 was purchased from
Midland Certified Reagent Co.
DNA substrates (approximately 50 fmol/reaction) were incubated with 5 units of top1 for 15 min at
25 °C with or without CPT in standard reaction buffer (10 mM Tris·HCl, pH 7.5, 50 mM KCl, 5 mM MgCl2, 0.1 mM EDTA, 15 µg/ml
bovine serum albumin). Reactions were stopped by adding either sodium
dodecyl sulfate (SDS) (final concentration 0.5%) or NaCl (unless
otherwise indicated, 0.5 M for 30 min at 25 °C followed
by addition of 0.5% SDS). Kinetics of reversal were performed by
adding NaCl (0.25 M final concentration) to the reactions
and incubating the samples at 10 °C for indicated times. Time-course
reactions were stopped with 0.5% SDS.
3.3
volumes of Maxam Gilbert loading buffer (98% formamide, 0.01 M EDTA, 1 mg/ml xylene cyanol, and 1 mg/ml bromophenol
blue) were added to the reaction mixtures before loading. 16%
denaturing polyacrylamide gels (7 M urea) were run at 40 V/cm at 50 °C for 2-3 h and dried on 3MM Whatman paper sheets.
Imaging and quantitations were performed using a PhosphorImager
(Molecular Dynamics, Sunnyvale, CA).
The substrates
used in these studies were derived from a Tetrahymena oligonucleotide
(17) containing a top1 cleavage site where adenine in +1 position on
the scissile (upper) strand was changed to a guanine to increase the
effect of camptothecin and its derivatives (Fig.
1A) (8). We first investigated the effect of
uracil incorporation at various positions in the nonscissile (lower)
strand on the DNA cleavage/religation equilibrium induced by top1 in
the presence or absence of CPT.
Cleavage activity of top1 was significantly altered, depending on the
uracil position. As shown in Fig. 2, three different effects were observed: (i) suppression of top1 cleavage when uracil was
incorporated at positions Modified oligonucleotides were used
to investigate the effect of abasic sites at given positions on the
top1 cleavage activity in the presence or absence of CPT. Depending on
the position of the abasic site, top1 cleavage activity was
differentially affected (Fig. 3). Abasic sites at
positions Enhancement of top1
cleavage in the absence of CPT was also observed using an
oligonucleotide containing a displaced loop (bulge) next to the
cleavage site on the nonscissile strand (Fig. 4A). Using different conditions of reversal,
such as increased concentration of sodium chloride (N) or
proteinase K (P) or heat treatment (H), we found
that top1 cleavage persisted under these conditions. Using this mispair
loop substrate, CPT had no further effect. With the control substrate,
CPT-induced DNA cleavage was completely reversed by salt, proteinase K,
or heat (Fig. 4B, left). Together, these results
demonstrate that top1 can cleave efficiently DNA with a bulge but fails
to religate the DNA, probably because of the stretching out of the loop
and separation of the acceptor DNA from the top1. This would generate a
suicide-type reaction.
Because the guanine at
position +1 on the scissile strand has been shown to increase the
specificity of CPT derivatives for top1 cleavable complexes (19), we
tested the effect of an uracil or an abasic site at this position.
Uracil mismatch (U:C) or wobble base pair (U:G) increased top1 cleavage
in the absence of CPT 8- and 7-fold, respectively (Fig.
5A, lanes 11, 12, 17, and
18). On the other hand, when an adenine was incorporated at
the +1 position on the lower strand, leading to a U:A base pairing, no cleavage difference was noted as compared with the control and CPT was
still active (Fig. 5A, lanes 5 and 6).
All corresponding substrates containing an abasic site also increased
top1 cleavage in the presence or the absence of CPT (Fig.
5A, lanes 8, 9, 14, 15, 20, and 21).
Reversal of cleavage was studied in the presence of 0.25 M
NaCl to investigate the irreversible nature of the cleavage. The
reaction rate of the top1-mediated religation process was decreased for
the control oligonucleotide in the presence of 10 µM CPT,
but reversal was complete after 15 min incubation (Fig. 5B),
which is consistent with previous findings indicating that CPT
reversibly inhibits the religation step of the top1 catalytic reaction
(12, 20, 21). Uracil incorporation at the +1 position on the scissile
strand did not affect the religation step in the absence of CPT, and
reversal was complete after 5 min. In contrast, the presence of an
abasic site at the same position inhibited the reversal of top1
cleavage, even when longer reversal times were used (Fig. 5B,
right panel, arrow), suggesting the formation of a suicide
product.
We further tested the effect of the abasic site at the +1
position by using a modified oligonucleotide synthesized with a tetrahydrofuran abasic site analogue at this position (Fig.
6A). The same irreversible trapping of top1
was observed in the absence or presence of camptothecin (Fig.
6B). Together, these results indicate that the presence of
an abasic site immediately 3 The present study demonstrates that uracil incorporation, DNA
mismatches, and abasic sites can have profound and contrasting effects
on top1 activity, depending on their position relative to the top1
cleavage site. Modifications within the first 4 bases immediately
upstream of the cleavage site (positions Uracil incorporation can result in true mismatches (C:U, T:U) or
abnormal base pairs (G:U or A:U). Yeh et al. (18) have reported that the mammalian all-type mismatch nicking enzyme forms a
cleavable complex with the 3 The effects of uracil incorporation 5 This is the first report of a top1-abasic site nicking activity that is
strongly dependent on the specific position of the abasic site relative
to the top1 cleavage site. A recent study of Osheroff and coworkers
(16) showed that mammalian topoisomerase II exhibits nicking activity
in DNA containing random chemically generated abasic sites. However, no
such activity was demonstrated for top1 in their conditions using
plasmid DNA. This could be attributed to the critical importance of the
position of the abasic site relative to the top1 cleavage sites. Thus,
the enhancing effects could have been masked by the suppressive effects
in their global analysis using a large DNA fragment. An abasic site
immediately 5 The presence of abasic sites had opposite (suppressive) effects when
they were located 5 As indicated in the introduction, spontaneous formation of uracil bases
by hydrolysis of cytosines and abasic sites by depurination, alkylation, or glycosylase action are among the most frequent DNA
lesions, with thousands of such lesions formed daily in any given human
cell (1). Loop mispairs have been implicated in mismatch repair (3).
The existence of top1 cleavable complexes associated with such lesions
has not been demonstrated in vivo to date except for the
observation of Yeh et al. (18) that top1 may correspond to
the all-type mismatch nicking enzyme. Assuming that damaged DNA can
trap cleavable complexes, several scenarios can be envisaged. First,
trapping of top1 cleavable complexes may play a role in DNA repair by
tagging the mismatches, recruiting DNA repair enzymes, and/or arresting
transcription and replication, and subsequently preventing errors. This
situation might be analogous to poly(ADP-ribose) polymerase, which
binds to single-strand breaks and may initiate DNA repair (30).
Alternatively, top1 trapping may exert lethal effects, as in the case
of top1 cleavable complexes trapped by camptothecin (5). This may
represent a way for cells with damaged DNA to be tagged for programmed
cell death. However, a fraction of the damaged cells may survive, and
the irreversible (suicide), as well as the reversible cleavable
complexes, as in the case of camptothecin, may lead to DNA
recombinations (15).
Volume 272, Number 12,
Issue of March 21, 1997
pp. 7792-7796
©1997 by The American Society for Biochemistry and Molecular Biology, Inc.
to the cleavage site suppressed normal top1 cleavage and
induced new top1 cleavage sites. Uracils immediately 3
to the cleavage
site increased cleavage and produced a camptothecin mimicking effect. A
mismatch with a bulge or abasic sites immediately 3
to the top1
cleavage site irreversibly trapped top1 cleavable complexes in the
absence of camptothecin and produced a suicide cleavage complex. These
results demonstrate that top1 activity is sensitive to physiological,
environmental, and pharmacological DNA modifications and that top1 can
act as a specific mismatch- and abasic site-nicking enzyme.
-phosphate of the cleaved strand and a
tyrosyl residue of the enzyme. These intermediates are commonly
referred to as cleavable complexes (4-6). Under physiological
conditions, top1 catalyzes the religation of the 5
-hydroxyl group of
the broken DNA. Camptothecin (CPT), a potent anticancer agent, inhibits
the religation step and transforms transient top1-linked DNA breaks
into more persistent breaks. Although the intimate mechanism of action
of CPT and its derivatives is not totally resolved, CPT probably forms
a ternary complex with the enzyme and the DNA (5, 7, 8). In the cell,
cleavable complexes can be converted into permanent DNA damage during
replication and transcription (9, 10). These irreversible reactions
have been referred to as "suicide reactions" because top1-cleavable complexes cannot religate their normal acceptor under these conditions (11, 12). top1 can then promote illegitimate recombination with various
double-stranded DNAs bearing a 5
-hydroxyl terminus (11-15). All of
these events may be responsible for cell death, converting top1 from an
essential enzyme to a cell poison (5, 7).
Chemicals
-32P-cordycepin 5
-triphosphate was purchased from New
England Nuclear (Boston, MA). Polyacrylamide was purchased from
Bio-Rad, Inc. (Richmond, CA). Calf thymus type I DNA topoisomerase was
purchased from Life Technologies, Inc. CPT was provided by Drs. Wani
and Wall (Research Triangle Institute, Research Triangle Park, NC). 10 mM aliquots of CPT were stored at
20 °C, thawed, and
diluted to 1 mM in dimethyl sulfoxide just before use.
-32P-labeled cordycepin using terminal
deoxynucleotidyl transferase (Stratagene, La Jolla, CA) as described
previously (15). The reaction mixture was subsequently centrifuged
through a G25 Sephadex column to remove the excess of unincorporated
cordycepin. Labeled scissile strand was then annealed to the same
concentration of unlabeled lower strands containing uracils at
different positions, or a cytosine bulge as described in Fig.
4A (15).
Fig. 1.
DNA substrate for topoisomerase-I cleavage.
A, a modified tetrahymena hexadecameric rDNA sequence
(underlined) with a strong top1 cleavage site, indicated by
the arrowhead, was used. Labeling was performed with
32P-labeled cordycepin (*A) at the 3
-terminus
of the scissile (upper) strand as described under "Experimental
Procedures." Cleavage at the normal site gives rise to a 19-mer
product as indicated. B, uracil replacements and abasic
sites were introduced at each of several positions (from
8 to +6) on
the lower strand and at position +1 on the upper strand. top1-mediated
cleavage is associated with the covalent linkage of the enzyme to the
3
-terminus of the broken DNA.
[View Larger Version of this Image (20K GIF file)]
Fig. 2.
Effects of uracil replacements on
topoisomerase I-mediated DNA cleavage. Oligonucleotides containing
uracils (
) at distinct positions of the lower
strand were annealed to the 3
-end-labeled upper strand (see DNA
sequence above panels). Double-stranded DNA was reacted with top1 in
the absence or presence of 10 µM CPT at 25 °C for 15 min. Different arrows (see above panels) and numbers
correspond to the position and the size of the cleavage products,
respectively. Lane 1 of each panel, DNA alone; lanes 2 and 3, +top1; lanes 4 and 5,
+top1 + 10 µM CPT. Reactions were stopped with 0.5% SDS
(lanes 2 and 4) or 0.5 M NaCl
(lanes 3 and 5) for 30 min at 25 °C.
A, uracil misincorporations upstream from the normal
cleavage site (positions
6 to
1; see Fig. 1). B, uracil
misincorporations downstream from the normal cleavage site (positions
+1 to +4).
[View Larger Version of this Image (64K GIF file)]
Fig. 3.
Effects of abasic sites on topoisomerase
I-mediated DNA cleavage. Oligonucleotide duplexes containing
abasic sites on the lower strand were incubated with top1 as described
in Fig. 2. Lane numbers are identical to those in Fig. 2. A,
abasic sites upstream from the normal cleavage site (positions
8 to
1; see Fig. 1). B, abasic sites downstream from the normal
cleavage site (positions +1 to +4). C, positions of the
cleavages are indicated by the different arrows.
[View Larger Version of this Image (49K GIF file)]
Fig. 4.
Topoisomerase I cleavage activity using a
displaced loop substrate. A, the 3
-labeled scissile strand
was annealed to a nonscissile strand containing three extra cytosines
between position +1 and +2, creating a loop in the double-stranded DNA substrate. B, substrates were reacted with top1 without
(
CPT) or with 10 µM CPT (+CPT) for 15 min at 25 °C.
Lanes 1 and 8, DNA alone; lanes 2 and
8-11, +top1; lanes 3-6 and 12-15,
+top1 + CPT. Reactions were stopped either with 0.5% SDS
(S), 0.5 M NaCl for 1 h at 25 °C
(N), proteinase K (0.5 mg/ml) for 1 h at 50 °C
(P), or heat for 1 h at 50 °C (H).
[View Larger Version of this Image (73K GIF file)]
Fig. 5.
Topoisomerase I-mediated DNA cleavage is
affected by uracil misincorporation and abasic sites in the scissile
strand. A, the oligonucleotide duplex shown in Fig. 1 was
modified at the +1 position by the replacements shown; D,
abasic site. These substrates were reacted with top1 for 30 min at
25 °C, and reactions were stopped with 0.5% SDS. Lanes 1, 4, 7, 10, 13, 16, and 19, DNA alone; lanes 2, 5, 8, 11, 14, 17, and 20, +top1; lanes 3, 6, 9, 12, 15, 18, and 21, +top1 + 10 µM CPT.
Arrows and numbers indicate the positions and the sizes of
the cleavage products. B, kinetics of reversal were studied
with substrates containing either an uracil or an abasic site at +1
position on the scissile strand (right panel) as compared
with the regular oligonucleotide (left panel). Substrates
were incubated with top1 in the absence (
CPT) or presence of 10 µM CPT (+CPT) for 15 min at 25 °C. Lane a
in each panel, DNA alone; lane b, +top1; lane c,
+top1 + 10 µM CPT. Reactions were reversed for 5-60 min
in 0.25 M NaCl at 10 °C. *, additional 15 min incubation
time at 37 °C following 60 min reversal. Lane d, the
abasic oligonucleotide was treated for 1 h at 25 °C with 10 mM NaOH (final concentration) to verify the presence of the
abasic site after uracil DNA glycosylase digestion. Under these
conditions, 80% of the abasic oligonucleotide was converted into the
nicked product.
[View Larger Version of this Image (68K GIF file)]
Fig. 6.
Effects of tetrahydrofuran abasic
oligonucleotide on top1-mediated DNA cleavage. A, structure
of the tetrahydrofuran abasic site at the +1 position on the scissile
strand. B, top1 reactions were performed as described in
Fig. 2. Lane 1, DNA alone; lanes 2 and
3, +top1; lanes 4 and 5, +top1 + 10 µM CPT. Reactions were stopped with 0.5% SDS
(lanes 2 and 4) or 0.5 M NaCl
(lanes 3 and 5) for 30 min at 25 °C.
[View Larger Version of this Image (29K GIF file)]
Effects of Uracil Incorporation and Mismatches
3,
2, and
1, and to a lesser extent at
position
4. This suppression was observed even in the presence of 10 µM CPT. These results show that uracil misincorporation within the 4 bases immediately upstream from the top1 site (5
to the
top1 cleavage site) suppresses DNA cleavage. Thus, modifications of DNA
in this region can markedly alter top1 catalytic activity. (ii)
Enhancement of top1 cleavage in the absence of CPT at the preexisting
site was observed when uracil was incorporated at either the
6,
5,
or +1 position (Fig. 2, compare lanes 2 for these positions
and lanes 2 for the controls). This enhancement was
7-10-fold compared with control, and this effect was still observed
for positions as far as
7 and
8 from the cleavage site (data not
shown). In all cases, cleavage was reversible upon addition of 0.5 M NaCl (Fig. 2, lanes 3 and 5). (iii)
Induction of a new top1 cleavage site was observed when uracils were
incorporated at positions
2 and
1 (Fig. 2A, white
arrow). In the case of the
2 mismatch, the new top1 cleavage
site was independent of CPT and was located immediately upstream from
the mismatch, which is consistent with the enhancement produced by a
mismatch at the +1 position. These data indicate that base mismatches
can trap top1 cleavable complexes (18).
4,
3,
2, and
1 suppressed top1 cleavage at the normal
site. New sites were also induced immediately upstream from the abasic
site when the abasic site was at position
5,
4, or
2. top1
cleavage was enhanced (4-5-fold) in the absence of CPT when the abasic
site was at positions
6,
2, and +1. This enhancement was associated
with an inhibition of religation when the abasic site was at position
2 or +1. This can be seen in Fig. 3 as a persistent cleavage band
(60-80% of the initial cleavage) after addition of salt (Fig. 3,
compare lanes 4 and 5 and lanes 2 and
3). It should be noted that the persistent site observed
with the oligonucleotide containing an abasic site at position
2
corresponds to an abasic site immediately downstream from the cleavage
site. The results observed both with the abasic sites at positions +1
and
2 indicate that the presence of an abasic site immediately
downstream from a top1 cleavage site enhances cleavage in the absence
of CPT by inhibiting DNA religation and induces suicide-type
reaction.
from the top1 Cleavage Site
to the top1 cleavage (position +1)
generates a suicide product.
1 to
4) generally
suppressed top1 cleavage, whereas modifications immediately downstream
(position +1) generally trapped top1 cleavable complexes.
-DNA terminus 5
to the eight possible types of DNA mismatches. They found that this mismatch nicking activity
was in fact an intrinsic activity of top1 (18). Nash and Robertson (22)
have also demonstrated that
-Int topoisomerase specifically cleaves
heteroduplex attachment sites containing mismatches. Consistent with
these results, we found that the true mismatch U:C (Fig. 5A)
resulted in enhanced top1 cleavage activity. However, we also found the
same enhancing effect when base pairing was retained as in the case of
the wobble base pairs G:U (Fig. 2B) or U:G (Fig.
5A). However, normal base pairing as in A:U had no effect on
the enzyme activity (data not shown). These results demonstrate that
abnormal DNA structure at the +1 position, immediately 3
to the top1
cleavage site, is more important than the presence of uracil per
se at this position. The study of Yeh et al. (18) also
demonstrated the influence of DNA sequence immediately flanking the
mismatch but did not investigate mismatches at specific sites relative
to the top1 cleavage sites. Our study suggests that the top1 mismatch
nicking activity exhibits selectivity for base mismatches immediately
downstream of the preexisting top1 cleavage site: primarily at the +1
position and to a lesser extent at the +2 position because no cleavage
enhancement was observed for mismatches at positions
1,
2, or
3
(23). This indicates that top1 can act as a mismatch-nicking enzyme
only at limited sites on the DNA and that such sites are primarily
determined by the enzyme. We also show for the first time that a
mispaired single-stranded loop (bulge) immediately 3
to the cleavage
site leads to an irreversible cleavage complex.
to the cleavage site depended on
its position and on the structure of the resulting base pair (true
mismatches C:U or T:U, wobble base pair G:U, or normal A:U base pair).
When uracil was close to the top1 cleavage site (positions
1,
2, or
3) and resulted in T:U or C:U mismatches, top1 cleavage was
suppressed. The lack of suppression by uracil incorporation at position
4 might be due to an insignificant structural modification of the DNA
because it resulted in an A:U base pair. When uracil was further
upstream, at positions
6,
7, or
8, also resulting in A:U base
pairs, top1-induced DNA cleavage was stimulated. Thus, major groove
contacts in this region upstream from the cleavage site appear to be
critical for enzyme activity (23-26). This result is consistent with a
previous study (27) showing that cytosine methylation at position
3
on the scissile strand suppressed top1 cleavage, whereas no such
suppression was observed at position
4. Together these observations
indicate that both base pairing and major groove structure at each
position upstream from the top1 cleavage site are critical for enzyme
activity (23-26).
(position +1 on the scissile or uncleaved strand) to the
cleavage site trapped irreversible top1-cleavable complexes (suicide
products). Enhanced top1 cleavage in the absence of camptothecin was
also observed with abasic sites at the +2 position and to a lesser extent at the +3 position. However, enhancement was less pronounced and
cleavable complexes were more reversible than for the abasic sites at
position +1. This is a camptothecin-mimetic effect (5). Under these
conditions, the religation step afterward is hindered by the abasic
site. This could be interpreted as a requirement for base pairing
immediately downstream from the top1-DNA linkage to align the cleaved
strand for religation.
to the top1 cleavage site, from position
1 to
position
4. This observation is consistent with the requirement of
optimum enzyme-DNA contact with a tetramer oligonucleotide immediately
upstream from the top1 site (23). Evidence for the close interaction of
mammalian top1 with the 4 base pairs immediately upstream from the top1
cleavage site has already been suggested from the uracil incorporation
data discussed above and from previous studies demonstrating that base preferences for top1 cleavage sites is strongest for the
1,
2,
3,
and
4 positions (19, 21, 28, 29).
*
The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom correspondence should be addressed: Building 37, Room
5C25, National Institutes of Health, Bethesda, MD 20892-4255. Fax:
(301) 402-0752; E-mail: pommiery{at}POserver-P.nih.gov.
1
The abbreviations used are: top1, topoisomerase
1; CPT, camptothecin.
©1997 by The American Society for Biochemistry and Molecular Biology, Inc.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
T. S. Dexheimer, A. Kozekova, C. J. Rizzo, M. P. Stone, and Y. Pommier The modulation of topoisomerase I-mediated DNA cleavage and the induction of DNA-topoisomerase I crosslinks by crotonaldehyde-derived DNA adducts Nucleic Acids Res., July 1, 2008; 36(12): 4128 - 4136. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. van der Merwe and M.-A. Bjornsti Mutation of Gly721 Alters DNA Topoisomerase I Active Site Architecture and Sensitivity to Camptothecin J. Biol. Chem., February 8, 2008; 283(6): 3305 - 3315. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Fung, P. Liu, and B. Demple ATF4-Dependent Oxidative Induction of the DNA Repair Enzyme Ape1 Counteracts Arsenite Cytotoxicity and Suppresses Arsenite-Mediated Mutagenesis Mol. Cell. Biol., December 15, 2007; 27(24): 8834 - 8847. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. F. El-Khamisy and K. W. Caldecott TDP1-dependent DNA single-strand break repair and neurodegeneration Mutagenesis, July 1, 2006; 21(4): 219 - 224. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Rieger, E. I. Zaika, W. Xie, F. Johnson, A. P. Grollman, C. R. Iden, and D. O. Zharkov Proteomic Approach to Identification of Proteins Reactive for Abasic Sites in DNA Mol. Cell. Proteomics, May 1, 2006; 5(5): 858 - 867. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. A. Rao, A. M. Fan, L. Meng, C. F. Doe, P. S. North, I. D. Hickson, and Y. Pommier Phosphorylation of BLM, Dissociation from Topoisomerase III{alpha}, and Colocalization with {gamma}-H2AX after Topoisomerase I-Induced Replication Damage Mol. Cell. Biol., October 15, 2005; 25(20): 8925 - 8937. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. C. Raymond, B. L. Staker, and A. B. Burgin Jr. Substrate Specificity of Tyrosyl-DNA Phosphodiesterase I (Tdp1) J. Biol. Chem., June 10, 2005; 280(23): 22029 - 22035. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z.-Y. Liao, O. Sordet, H.-L. Zhang, G. Kohlhagen, S. Antony, W. H. Gmeiner, and Y. Pommier A Novel Polypyrimidine Antitumor Agent FdUMP[10] Induces Thymineless Death with Topoisomerase I-DNA Complexes Cancer Res., June 1, 2005; 65(11): 4844 - 4851. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. C. A. M. van Waardenburg, L. A. de Jong, M. A. J. van Eijndhoven, C. Verseyden, D. Pluim, L. E. T. Jansen, M.-A. Bjornsti, and J. H. M. Schellens Platinated DNA Adducts Enhance Poisoning of DNA Topoisomerase I by Camptothecin J. Biol. Chem., December 24, 2004; 279(52): 54502 - 54509. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Sordet, Q. A. Khan, I. Plo, P. Pourquier, Y. Urasaki, A. Yoshida, S. Antony, G. Kohlhagen, E. Solary, M. Saparbaev, et al. Apoptotic Topoisomerase I-DNA Complexes Induced by Staurosporine-mediated Oxygen Radicals J. Biol. Chem., November 26, 2004; 279(48): 50499 - 50504. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Antony, J. A. Theruvathu, P. J. Brooks, D.-T. Lesher, M. Redinbo, and Y. Pommier Enhancement of camptothecin-induced topoisomerase I cleavage complexes by the acetaldehyde adduct N2-ethyl-2'-deoxyguanosine Nucleic Acids Res., October 21, 2004; 32(18): 5685 - 5692. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Antony, P. B. Arimondo, J.-S. Sun, and Y. Pommier Position- and orientation-specific enhancement of topoisomerase I cleavage complexes by triplex DNA structures Nucleic Acids Res., October 4, 2004; 32(17): 5163 - 5173. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Tian, J. M. Sayer, D. M. Jerina, and S. Shuman Individual Nucleotide Bases, Not Base Pairs, Are Critical for Triggering Site-specific DNA Cleavage by Vaccinia Topoisomerase J. Biol. Chem., September 17, 2004; 279(38): 39718 - 39726. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. Rideout, A. C. Raymond, and A. B. Burgin Jr Design and synthesis of fluorescent substrates for human tyrosyl-DNA phosphodiesterase I Nucleic Acids Res., August 27, 2004; 32(15): 4657 - 4664. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Sordet, Z. Liao, H. Liu, S. Antony, E. V. Stevens, G. Kohlhagen, H. Fu, and Y. Pommier Topoisomerase I-DNA Complexes Contribute to Arsenic Trioxide-induced Apoptosis J. Biol. Chem., August 6, 2004; 279(32): 33968 - 33975. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Daroui, S. D. Desai, T.-K. Li, A. A. Liu, and L. F. Liu Hydrogen Peroxide Induces Topoisomerase I-mediated DNA Damage and Cell Death J. Biol. Chem., April 9, 2004; 279(15): 14587 - 14594. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. C.A.M. van Waardenburg, L. A. de Jong, F. van Delft, M. A.J. van Eijndhoven, M. Bohlander, M.-A. Bjornsti, J. Brouwer, and J. H.M. Schellens Homologous recombination is a highly conserved determinant of the synergistic cytotoxicity between cisplatin and DNA topoisomerase I poisons Mol. Cancer Ther., April 1, 2004; 3(4): 393 - 402. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. R. Kang, M. T. Muller, and I. K. Chung Telomeric DNA Damage by Topoisomerase I: A POSSIBLE MECHANISM FOR CELL KILLING BY CAMPTOTHECIN J. Biol. Chem., March 26, 2004; 279(13): 12535 - 12541. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Malanga and F. R. Althaus Poly(ADP-ribose) Reactivates Stalled DNA Topoisomerase I and Induces DNA Strand Break Resealing J. Biol. Chem., February 13, 2004; 279(7): 5244 - 5248. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Liu, L. Yan, J. R. Donze, and S. L. Gerson Blockage of abasic site repair enhances antitumor efficacy of 1,3-bis-(2-chloroethyl)-1-nitrosourea in colon tumor xenografts Mol. Cancer Ther., October 1, 2003; 2(10): 1061 - 1066. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Yoshida, Y. Urasaki, M. Waltham, A.-C. Bergman, P. Pourquier, D. G. Rothwell, M. Inuzuka, J. N. Weinstein, T. Ueda, E. Appella, et al. Human Apurinic/Apyrimidinic Endonuclease (Ape1) and Its N-terminal Truncated Form (AN34) Are Involved in DNA Fragmentation during Apoptosis J. Biol. Chem., September 26, 2003; 278(39): 37768 - 37776. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. Chrencik, A. B. Burgin, Y. Pommier, L. Stewart, and M. R. Redinbo Structural Impact of the Leukemia Drug 1-beta -D-Arabinofuranosylcytosine (Ara-C) on the Covalent Human Topoisomerase I-DNA Complex J. Biol. Chem., March 28, 2003; 278(14): 12461 - 12466. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Stephan, F. Grosse, and K. Soe Human topoisomerase I cleavage complexes are repaired by a p53-stimulated recombination-like reaction in vitro Nucleic Acids Res., December 1, 2002; 30(23): 5087 - 5093. [Abstract] [Full Text] [PDF] |
||||
![]() |
D.-T. T. Lesher, Y. Pommier, L. Stewart, and M. R. Redinbo 8-Oxoguanine rearranges the active site of human topoisomerase I PNAS, September 17, 2002; 99(19): 12102 - 12107. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Liu, Y. Nakatsuru, and S. L. Gerson Base Excision Repair as a Therapeutic Target in Colon Cancer Clin. Cancer Res., September 1, 2002; 8(9): 2985 - 2991. [Ab |